We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microphysiometer Can Assess Bioterrorism Agents

By Biotechdaily staff writers
Posted on 19 Jan 2004
A new device that monitors the metabolism of living cells in near real-time can analyze and defend against novel bioterrorism agents.

The device is a four-channel microphysiometer, a modification of an older device called the Cytosensor that measures changes in acidity in a small chamber holding between 100,000-1,000,000 individual cells. More...
Researchers have added three additional sensors so they can simultaneously chart minute-by-minute variations in the concentrations of oxygen, glucose, and lactic acid, in addition to pH. This is important since the basic metabolism of a cell involves consuming oxygen and glucose and producing lactic and carbonic acid. So monitoring variations in these four chemicals allows researchers to quickly assess the impact that exposure to different chemicals have on the activity and health of small groups of cells.

In addition to its potential application for bioterrorism, the microphysiometer has potential applications in detecting and assessing the toxicity of environmental pollutants. The device consists of a series of reservoirs, switches, rotary pumps, and tiny chambers made from two thin membrane sheets that contain the cell colonies. The researchers have been using the device to study cell response to a number of different chemical and biologic agents, including pesticides and pollutants.

"So far we have been lucky that terrorists have used well-known biologic agents like anthrax and sarin gas,” said David Cliffel, assistant professor of chemistry at Vanderbilt University (Nashville, TN, USA; www.vanderbilt.edu), who led the development group. But how will we respond if one of these groups uses recent advances in genetic engineering to produce an agent that is new and unknown?”

Vanderbilt >> www.vanderbilt.edu

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.